Is the gout drug Febuxostat safe for cardiovascular disease? The Lancet published a large multinational trial 39987 consumables winning bid results announced (attached list) Significantly improve skin ...

Gaze into the 2025 sporting crystal ball and you may see something you like - or you may see your NRL team miss the eight.

INR:4175. city football group Kidney disease clinical trials are expected to use new clinical endpoints to accelerate the development of new drugs Genetic tes ...

A new study published in the journal of The Lancet Rheumatology showed that individuals with gout who started urate-lowering ...

A recent study in ACR Open Rheumatology identified which patients were most likely to underreport experiencing or ...

Researchers from Nanjing University and Peking University presented the discovery and preclinical characterization of novel NLRP3 inhibitors as potential therapeutic candidates for the treatment of ...

Thompson, 23, was the breakthrough sprinter of the year, and ended 2024 with the fastest time of 9.77, recorded as he won the ...

He has only just turned 16, but already the Aussie sprinting superstar tipped to be better than Usain Bolt has become a multi ...

Lowering urate levels with urate-lowering therapy was not associated with an increased risk for severe or end-stage kidney ...

A recent analysis of the LoDoCo2 (Low-Dose Colchicine 2) trial suggests that taking a low daily dose of colchicine may reduce ...

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

World Athletics President Sebastian Coe said on Tuesday that 16-year-old Australian sprint sensation Gout Gout was a rare talent but he will need "nurturing and protecting".